 John Rice
Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas Infections | 1 | 2022 | 184 | 0.710 |
Why?
| | Critical Illness | 5 | 2023 | 644 | 0.590 |
Why?
| | Cystic Fibrosis | 1 | 2022 | 955 | 0.420 |
Why?
| | Hyperoxia | 3 | 2023 | 99 | 0.420 |
Why?
| | Breast Neoplasms | 1 | 2022 | 1862 | 0.370 |
Why?
| | Rhinitis | 2 | 2023 | 128 | 0.370 |
Why?
| | Sinusitis | 2 | 2023 | 174 | 0.350 |
Why?
| | Brain Injuries, Traumatic | 2 | 2023 | 301 | 0.310 |
Why?
| | Papillomavirus Vaccines | 2 | 2020 | 223 | 0.290 |
Why?
| | Papillomavirus Infections | 2 | 2020 | 261 | 0.280 |
Why?
| | Vaccines | 2 | 2022 | 375 | 0.270 |
Why?
| | Vaccination Refusal | 3 | 2021 | 69 | 0.260 |
Why?
| | Patient Acceptance of Health Care | 5 | 2022 | 681 | 0.250 |
Why?
| | Parents | 6 | 2022 | 1186 | 0.240 |
Why?
| | Vaccination | 6 | 2022 | 1204 | 0.240 |
Why?
| | Chronic Disease | 4 | 2023 | 1578 | 0.230 |
Why?
| | Oxygen | 3 | 2023 | 854 | 0.210 |
Why?
| | Stroke | 2 | 2022 | 1021 | 0.210 |
Why?
| | Pseudomonas | 1 | 2022 | 26 | 0.200 |
Why?
| | Endothelin-2 | 1 | 2021 | 2 | 0.190 |
Why?
| | Private Practice | 1 | 2020 | 20 | 0.180 |
Why?
| | Guideline Adherence | 2 | 2022 | 490 | 0.180 |
Why?
| | Bone Remodeling | 1 | 2021 | 65 | 0.180 |
Why?
| | Prescription Drugs | 1 | 2022 | 116 | 0.180 |
Why?
| | Mentoring | 1 | 2022 | 100 | 0.170 |
Why?
| | Humans | 26 | 2023 | 114623 | 0.170 |
Why?
| | Stakeholder Participation | 1 | 2020 | 73 | 0.170 |
Why?
| | Hospitalists | 1 | 2023 | 174 | 0.170 |
Why?
| | Community Participation | 1 | 2020 | 116 | 0.170 |
Why?
| | Safety-net Providers | 1 | 2021 | 95 | 0.170 |
Why?
| | Diet, High-Fat | 1 | 2021 | 225 | 0.170 |
Why?
| | Drug Resistant Epilepsy | 1 | 2019 | 45 | 0.160 |
Why?
| | Brain Injuries | 1 | 2023 | 461 | 0.150 |
Why?
| | Respiratory Tract Infections | 1 | 2021 | 319 | 0.150 |
Why?
| | Plant Extracts | 1 | 2019 | 154 | 0.150 |
Why?
| | Referral and Consultation | 1 | 2022 | 632 | 0.150 |
Why?
| | Medical Marijuana | 1 | 2019 | 97 | 0.150 |
Why?
| | Prospective Studies | 7 | 2023 | 6217 | 0.150 |
Why?
| | Anticonvulsants | 1 | 2019 | 179 | 0.150 |
Why?
| | Intensive Care Units | 1 | 2021 | 617 | 0.140 |
Why?
| | Patient Discharge | 1 | 2023 | 771 | 0.140 |
Why?
| | Female | 12 | 2023 | 59466 | 0.140 |
Why?
| | Influenza Vaccines | 1 | 2021 | 497 | 0.130 |
Why?
| | Health Knowledge, Attitudes, Practice | 5 | 2022 | 1183 | 0.130 |
Why?
| | Sleep | 1 | 2021 | 631 | 0.130 |
Why?
| | Mass Screening | 1 | 2022 | 1004 | 0.130 |
Why?
| | Influenza, Human | 1 | 2021 | 546 | 0.130 |
Why?
| | Pneumonia | 1 | 2021 | 567 | 0.130 |
Why?
| | Healthcare Disparities | 1 | 2021 | 479 | 0.120 |
Why?
| | Disease Progression | 1 | 2022 | 2380 | 0.120 |
Why?
| | Emergency Medical Services | 1 | 2022 | 590 | 0.120 |
Why?
| | Wounds and Injuries | 1 | 2021 | 745 | 0.110 |
Why?
| | Cannabis | 1 | 2019 | 384 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1477 | 0.100 |
Why?
| | Oximetry | 2 | 2023 | 81 | 0.100 |
Why?
| | Sentinel Lymph Node Biopsy | 1 | 2011 | 99 | 0.090 |
Why?
| | Inflammation | 1 | 2021 | 2477 | 0.090 |
Why?
| | Asthma | 1 | 2021 | 2029 | 0.080 |
Why?
| | Lymph Nodes | 1 | 2011 | 419 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2094 | 0.080 |
Why?
| | Retrospective Studies | 5 | 2023 | 12542 | 0.080 |
Why?
| | Child | 6 | 2023 | 18404 | 0.080 |
Why?
| | Sex Characteristics | 2 | 2023 | 640 | 0.070 |
Why?
| | Models, Statistical | 1 | 2011 | 599 | 0.070 |
Why?
| | Child, Preschool | 4 | 2021 | 9108 | 0.070 |
Why?
| | Databases, Factual | 2 | 2023 | 1124 | 0.070 |
Why?
| | Male | 9 | 2023 | 55554 | 0.070 |
Why?
| | United States | 4 | 2022 | 12176 | 0.060 |
Why?
| | Melanoma | 1 | 2011 | 619 | 0.060 |
Why?
| | Infant | 3 | 2022 | 7959 | 0.060 |
Why?
| | Adolescent | 5 | 2021 | 17831 | 0.060 |
Why?
| | Hospitalization | 2 | 2023 | 1749 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2023 | 4405 | 0.050 |
Why?
| | Tryptases | 1 | 2022 | 10 | 0.050 |
Why?
| | Emergency Medical Dispatch | 1 | 2022 | 6 | 0.050 |
Why?
| | Colorado | 2 | 2022 | 4099 | 0.050 |
Why?
| | Substance P | 1 | 2022 | 44 | 0.050 |
Why?
| | Adult | 5 | 2023 | 30528 | 0.050 |
Why?
| | Information Systems | 1 | 2022 | 61 | 0.050 |
Why?
| | Quality of Life | 2 | 2023 | 2353 | 0.050 |
Why?
| | Workflow | 1 | 2022 | 133 | 0.050 |
Why?
| | Osteocalcin | 1 | 2021 | 34 | 0.050 |
Why?
| | Estrous Cycle | 1 | 2021 | 14 | 0.050 |
Why?
| | Ovulation | 1 | 2021 | 39 | 0.050 |
Why?
| | Respiratory Sounds | 1 | 2021 | 110 | 0.050 |
Why?
| | Collagen Type I | 1 | 2021 | 108 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2021 | 248 | 0.050 |
Why?
| | Endoscopy | 1 | 2023 | 246 | 0.040 |
Why?
| | Patient Outcome Assessment | 1 | 2021 | 122 | 0.040 |
Why?
| | Guatemala | 1 | 2020 | 266 | 0.040 |
Why?
| | Middle Aged | 4 | 2022 | 26719 | 0.040 |
Why?
| | Ovary | 1 | 2021 | 191 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2022 | 739 | 0.040 |
Why?
| | Sleep Deprivation | 1 | 2021 | 166 | 0.040 |
Why?
| | Decision Support Systems, Clinical | 1 | 2021 | 176 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2023 | 9084 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2023 | 1691 | 0.040 |
Why?
| | Cannabidiol | 1 | 2019 | 60 | 0.040 |
Why?
| | Length of Stay | 1 | 2023 | 962 | 0.040 |
Why?
| | Hospitals | 1 | 2023 | 581 | 0.040 |
Why?
| | Dronabinol | 1 | 2019 | 118 | 0.040 |
Why?
| | Respiration, Artificial | 1 | 2021 | 529 | 0.040 |
Why?
| | Administration, Oral | 1 | 2019 | 728 | 0.040 |
Why?
| | Inpatients | 1 | 2021 | 380 | 0.040 |
Why?
| | Medicare | 1 | 2022 | 665 | 0.040 |
Why?
| | Communication | 1 | 2022 | 744 | 0.030 |
Why?
| | Pilot Projects | 1 | 2021 | 1372 | 0.030 |
Why?
| | Aged | 3 | 2022 | 19061 | 0.030 |
Why?
| | Hospital Mortality | 1 | 2021 | 776 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1214 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2021 | 6344 | 0.030 |
Why?
| | Algorithms | 1 | 2023 | 1466 | 0.030 |
Why?
| | Hypoxia | 1 | 2021 | 957 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 771 | 0.030 |
Why?
| | Prevalence | 1 | 2020 | 2249 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2022 | 1394 | 0.030 |
Why?
| | Quality Improvement | 1 | 2021 | 950 | 0.030 |
Why?
| | Exercise | 1 | 2022 | 1644 | 0.020 |
Why?
| | Risk Assessment | 1 | 2021 | 2967 | 0.020 |
Why?
| | Young Adult | 2 | 2021 | 10455 | 0.020 |
Why?
| | Support Vector Machine | 1 | 2011 | 34 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 3408 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 5043 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 4620 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2011 | 1167 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 8628 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 1796 | 0.020 |
Why?
| | Mice | 1 | 2021 | 14860 | 0.020 |
Why?
| | Prognosis | 1 | 2011 | 3328 | 0.010 |
Why?
| | Animals | 1 | 2021 | 31694 | 0.010 |
Why?
|
|
Rice's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|